Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.34M 1.21M 2.28M 157M 2.29M 15.9M 6.11M 79.74M 6.16M 6.03M 252M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7M 6.63M 6.01M 11.28M 777M 11.33M 78.76M 30.29M 395M 30.53M 29.86M 1.25B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
+2.56%+1.66%+52.71%+93.13% 994B
+1.09%-0.25%+51.33%+63.96% 640B
+2.03%+5.33%+20.41%+70.55% 454B
+4.98%+2.18%+38.75%+39.20% 337B
+1.92%-8.86%+17.08%+25.33% 261B
+3.34%+0.71%+6.26%+12.15% 246B
+0.33%-3.69%+38.00%+44.37% 204B
+1.43%-6.21%-21.04%-58.94% 190B
+1.15%-0.93%+29.09%+87.80% 178B
Average +991.89%-5.18%+23.26%+37.75% 350.48B
Weighted average by Cap. +2.22%-4.42%+34.97%+57.62%

Financials

2007 2008
Net sales 23.47M 20.22M 19.14M 17.35M 32.55M 2.24B 32.72M 227M 87.44M 1.14B 88.13M 86.2M 3.6B 25.96M 22.37M 21.18M 19.2M 36.01M 2.48B 36.2M 252M 96.73M 1.26B 97.49M 95.35M 3.99B
Net income -20.86M -17.97M -17.02M -15.42M -28.94M -1.99B -29.08M -202M -77.72M -1.01B -78.33M -76.62M -3.2B -4.01M -3.45M -3.27M -2.96M -5.56M -383M -5.59M -38.81M -14.93M -195M -15.04M -14.71M -615M
Net Debt 18.79M 16.19M 15.33M 13.89M 26.07M 1.8B 26.2M 182M 70.01M 913M 70.57M 69.02M 2.89B 6.49M 5.59M 5.29M 4.8M 9M 620M 9.05M 62.87M 24.18M 315M 24.37M 23.83M 997M
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!